February 2026
The peptide synthesis market size was valued at USD 678.12 million in 2025 and is expected to attain around USD 1,438.78 million by 2035 with a CAGR of 7.81%.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The global peptide api market size is estimated to hit around USD 100.16 billion by 2035, increasing from USD 62.01 billion in 2025, with a CAGR of 4.91%.
June 2026
The global pharmaceutical impurity synthesis and isolation services market size was valued at USD 1.35 billion in 2025 and is expected to hit around USD 2.93 billion by 2035, at a CAGR of 8.06%.
June 2026
The US DNA synthesis market size was evaluated at USD 1.90 billion in 2025 and is predicted to hit around USD 10.66 billion by 2035, growing at a CAGR of 18.82%.
May 2026
The cell penetrating peptide market size was estimated at USD 2.48 billion in 2025 and is expected to hit around USD 9.95 billion by 2035, growing at a CAGR of 14.9%.
May 2026
The global peptide therapeutics contract API manufacturing market size is estimated to hit around USD 9.02 billion by 2035 from USD 3.84 billion in 2025, at a CAGR of 9.02%.
May 2026
The peptide therapeutics market size is expected to increase from USD 52.59 billion in 2025 to nearly USD 87.21 billion by 2035 with a notable CAGR of 5.19%.
May 2026
The global oligonucleotide synthesis market size is expected to increase from USD 4.90 billion in 2025 to hit around USD 12.65 billion by 2035, growing at a CAGR of 9.95%.
May 2026
The global mRNA synthesis raw materials market size was evaluated at USD 2.22 billion in 2025 and is predicted to hit around USD 8.37 billion by 2035, growing at a CAGR of 14.21 %.
May 2026
The global injectable peptides drugs market size was evaluated at USD 48.60 billion in 2025 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
April 2026
The global circRNA synthesis market size is accounted to hit around USD 909.12 million by 2035 increasing from USD 214.22 million in 2025, with a CAGR of 15.55%.
February 2026
The global mRNA synthesis and manufacturing market size is estimated to hit around USD 5.64 billion by 2035 increasing from USD 3.19 billion in 2025, with a CAGR of 5.85%.
February 2026
The global DNA synthesis market size has been calculated at USD 5.93 billion in 2025 and is projected to reach around USD 34.39 billion by 2035, with a CAGR of 19.22%.
February 2026
The global marine peptide market size was evaluated at USD 308.25 million in 2025 and is predicted to hit around USD 547.88 million by 2035, growing at a CAGR of 5.92%.
January 2026
The global gene synthesis market size is calculated at USD 4.00 billion in 2025 and is projected to hit around USD 32.97 billion by 2035 with a CAGR of 23.48%.
January 2026
The U.S. mRNA synthesis raw materials market size is estimated to hit around USD 2,588.71 million by 2035 increasing from USD 682.25 million in 2025, with a CAGR of 14.26%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
January 2026
The global oral protein and peptide market size was evaluated at USD 9.43 billion in 2025 and is predicted to hit around USD 47.63 billion by 2035, growing at a CAGR of 17.58%.
January 2026
The global digital breast tomosynthesis equipment market size was valued at USD 4.62 billion in 2025 and is expected to hit around USD 17.06 billion by 2035, growing at a CAGR of 13.96%.
July 2025
The artificial photosynthesis market size is expected to surpass around USD 317.96 million by 2034 from USD 83.39 million in 2024 with a solid CAGR of 14.32%.
July 2025
The global nanoparticle synthesis system market size was estimated at USD 1.54 billion in 2024 and is expected to hit around USD 4.19 billion by 2034, growing at a CAGR of 10.54%.
January 2025
The global tuna peptides market size is estimated to hit around USD 1.64 billion by 2034 increasing from USD 1.02 billion in 2024, with a CAGR of 4.86%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com